Merck KGaA: Adrenalin shot

Investors’ hearts pumping as Sigma-Aldrich in life sciences area

Merck to buy US’s Sigma-Aldrich for $17bn

German company to pay $140 a share in cash

NHS drug evaluation review called for

Nice chairman urges review of ‘innovation, evaluation and adoption’

GSK’s pain from scandal likely to linger

Guilty verdict may be just the start of its woes

GSK in China: doctor’s orders

Near $500m fine means business practices must change

GSK picks good day to report bribery fine

Bribery settlement with Chinese comes amid flurry of other news

GSK to pay £297m fine for Chinese bribes

Former head of China unit given suspended sentence

Timeline: GSK’s mounting woes in China

High-profile investigation alleged bribery on ‘massive scale’

Glaxo to pay £297m in China bribery case

Pharma group found guilty of bribing non-governmental personnel

Rite Aid cuts profit forecast

Shares fall 19 per cent after warning

US Drugstores: Bitter pill to swallow

Drug retailing in the US is a race to the bottom

Europe struggles to catch US biotech bulls

The Nasdaq biotech index is on the rise again

Volunteer given experimental Ebola vaccine

UK trial fast-tracked in response to outbreak in West Africa

Nice urges review of new drug adoption

Regulator wants broad debate on access to new medicines

AstraZeneca faces up to bittersweet moment

$500m tie-up recognises neuroscience costs but has greater chance of success

Drugmakers unite to tackle Alzheimer’s

Gilead signs deal with India drugmakers

Tie-up with generic producers aims to give affordable access to hepatitis drug Sovaldi

Tougher UK rules proposed for deal promises

Changes come after failed Pfizer bid for AstraZeneca

US more open to obesity drugs

Novo Nordisk medicine liraglutide given nod by US FDA

BAT nicotine inhaler wins medical approval

Quick-hit product could be on sale in shops next year


More FT Twitter accounts